Login / Register The Most Trusted Name in Medical Education

Allergy & Immunology

From asthma to shingles, we offer complimentary CME courses for a variety of Allergy & Immunology CME credits.

2018 9 116x140

Symptoms and Underlying Pathology in the Diagnosis and Optimal Management of Atopic Dermatitis

Format: Webcast

Symptoms and Underlying Pathology in the Diagnosis and Optimal Management of Atopic Dermatitis (AD): A 5-part Elsevier Learning Center. 

Take Course »

Credits: Up to 1.0 AMA PRA Category 1 Credit™ ; Up to 1.0 ANCC Contact Hours per module
116x140 AZ Spec SNAP

Focusing on Patients With Severe Asthma: From Guideline Recommendations to Daily Clinical Decision-Making

Format: Webcast Series

Welcome to this Severe Asthma CME Snapshot ™ video series. Each 15-minute module offers focused, clinically actionable education for pulmonologists, clinical immunologists, and other clinicians who manage patients with severe asthma. For a comprehensive curriculum that provides a practical set of recommendations to improve daily functioning and quality of life among patients with severe asthma, clinician learners can complete all 4 modules for a full hour of AMA PRA Category 1 Credit ™. 

Take Course »

Credits: 0.25 AMA PRA Category 1 Credit™ per module
1 BANNER

Management of Patients with Relapsed/Refractory Multiple Myeloma: Elsevier CME Independent Conference Highlights from EBMT and EHA 2018

Format: Conference Reporter

*This webcast is not endorsed by the conference organizer. The Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference-coverage educational programs.

In this CME-accredited webcast, three experts discuss the clinical implications of some of the latest important research on relapsed/refractory multiple myeloma (RRMM). The roundtable discussion covers new data presented at the 2018 annual meetings of the European Hematology Association (EHA) and the European Society for Blood and Marrow Transplantation (EBMT). The topics discussed include: unmet needs in the treatment of RRMM; new data on treatment strategies (including the roles of proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies); and emerging treatments, such as chimeric antigen receptor (CAR) T-cell therapies.

Credits: 1.0 AMA PRA Category 1 Credit™
116x141

ADVANCING THE CARE OF SEVERE ASTHMA: Differential Diagnosis, Multidisciplinary Management, and Patient Engagement

Format: Webcast Series

Welcome to this Severe Asthma CME Snapshot ™ video series. Each 15-minute module offers focused, clinically actionable education for primary care providers and other clinicians who manage patients with severe asthma. For a comprehensive curriculum that provides a practical set of recommendations on improving daily functioning and quality of life among patients with severe asthma, clinician learners can complete all 4 modules for a full hour of AMA PRA Category 1 Credit ™.

Take Course »

Credits: 0.25 AMA PRA Category 1 Credit™ per module
910799 116 x 140

ATS 2018: An Update on Scientific Advances and Clinical Strategies in Chronic Obstructive Pulmonary Disease (COPD)

Format: Conference Reporter

The American Thoracic Society (ATS) International Conference was held in San Diego, California, May 18-23, 2018. The ATS International Conference is the longest-running, large-scale conference in the world offering groundbreaking research in pulmonary, critical care, and sleep medicine. In this activity, 2 experts summarize the key learnings from this year’s conference focusing on strategies in chronic obstructive pulmonary disease (COPD).

*This webcast is not endorsed by the conference organizer. Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference coverage educational programs.

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
910701 116 x 144

Breathing Life Into COPD Management: Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care

Format: Webcast Series

This CME-accredited CME Snapshot™ educational series, Breathing Life Into COPD Management: Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care is intended for primary care clinicians and other health care providers involved in the ongoing management of patients with chronic obstructive pulmonary disease (COPD). Within each focused activity, an expert pulmonologist and a primary care educator discuss best practices for a specific aspect of managing patients with COPD, including monitoring the disease course over time, maximizing patient function, and individualizing treatment regimens. One activity also addresses patients’ perspectives by incorporating patient-clinician interactions and insights into disease burdens, challenges to good long-term outcomes, and shared decision-making. 

Take Course »

 

Credits: Up to 1.00 AMA PRA Category 1 Credit(s)™
910730 LC 116 x 140

Clinical Advances in Chronic Obstructive Pulmonary Disease: A Focus on Improving Patient Outcomes Learning Center

Format: Resource Center

Welcome to Clinical Advances in Chronic Obstructive Pulmonary Disease: A Focus on Improving Patient Outcomes Learning Center. The Learning Center provides you with free access to the latest clinical information relating to the diagnosis and management of COPD. The COPD Learning Center is a freely accessible platform that aims to increase clinical knowledge by providing continuing medical educational (CME) activities, research articles and resources for healthcare providers who treat patients with COPD.

Go to Learning Center »

910729 116 x 140

CHEST 2017: AN UPDATE ON SCIENTIFIC ADVANCES AND CLINICAL STRATEGIES IN COPD

Format: Conference Reporter

The CHEST Annual Meeting 2017 was held in Toronto, Ontario, Canada, October 28–November 1, 2017. As the premier chest medicine education meeting for clinicians, CHEST unites leaders to discuss current pulmonary, critical care, and sleep medicine topics. In this activity, 2 experts summarize the key learnings from this year’s Annual Meeting, focusing on chronic obstructive pulmonary disease (COPD).

Take Course »

 

Credits: 1.00 AMA PRA Category 1 Credit™
116x140

Looking Beneath the Surface in Atopic Dermatitis: Targeting Immune Dysregulation and Delivering Comprehensive Care

Format: Webcast

This Interactive Exchange™ program will open with a brief 3D-animated video focused on the pathophysiologic underpinnings of atopic dermatitis. Expert faculty will then discuss best practices for comprehensive patient evaluations and the clinical profiles of systemic treatment options for patients with moderate-to-severe disease. With an overall goal of improving patient outcomes, this educational session has been designed to allow internationally recognized experts to translate the latest published evidence into actionable recommendations for individualized patient care.

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
910694 116 x 140

Focus on Idiopathic Pulmonary Fibrosis: Advancing Approaches to Diagnosis, Prognosis and Treatment

Format: Webcast

Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic progressive fibrotic lung disease of unknown cause. Early diagnosis is a prerequisite for earlier treatment and, potentially, improved long-term clinical outcomes. Familiarity with novel treatment approaches that hold the promise of slowing disease progression and with the recent guideline recommendations is essential for all clinicians involved in the care of patients with IPF. Individualizing treatment is important in light of potential improved adherence to both drug therapy and health behaviors.

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
Elsevier SITC ASCO 2018 01 Web 116x140 webcast

The IO Quiz Show: Biomarkers for Immunotherapy

Format: Webcast

This webcast was recorded at a live event at ASCO SITC 2018. During this event, three leading experts challenged participants with quiz questions, which formed a basis for in-depth discussions supported by slide presentations. Participants were able to test and expand their knowledge on the increasingly important role of biomarkers in immuno-oncology. The experts examined the tumor microenvironment and addressed the evidence base for, and the future potential of, current and emerging biomarkers in guiding treatment decisions and in predicting the response to immuno-oncology therapeutics. Participants also learned about the role and importance of next-generation sequencing for the evaluation of novel immune biomarkers and for daily clinical practice.

Take Course »

Credits: 1.0 AMA PRA Category 1 Credits™
ASH 2017 IMMUNO banner 116x140 thumbnail

Immunotherapy in Hematological Malignancies

Format: Webcast

This is a CME-accredited Elsevier Conference Reporter webcast based on a virtual roundtable discussion on immunotherapy in hematological malignancies. During the discussion three key opinion leaders summarize and give their expert opinion on important data from abstracts presented at the American Society of Hematology (ASH) 2017 Annual Meeting. The webcast lasts approximately 1 hour.

*This webcast is not endorsed by the conference organizer. Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference coverage educational programs.

Take Course »

Credits: 1.00 AMA PRA Category 1 Credit(s)™
ASH 2017 Update MM banner 116x140

Management of Patients With Relapsed and/or Refractory Multiple Myeloma

Format: Webcast

This is a CME-accredited Elsevier Conference Reporter webcast based on a virtual roundtable discussion on the management of patients with relapsed and/or refractory multiple myeloma. During the virtual roundtable discussion, 3 experts summarize and give their expert opinion on important data from abstracts presented at the American Society of Hematology Association (ASH) 2017 Annual Meeting.

*This webcast is not endorsed by the conference organizer. Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference-coverage educational programs.

Take Course »

Credits: 1.00 AMA PRA Category 1 Credit(s)™
910797 116 x 140

ATS 2018: An Update on Scientific Advances and Clinical Strategies in Interstitial Lung Disease (ILD)

Format: Conference Reporter

The American Thoracic Society (ATS) International Conference was held in San Diego, California, May 18-23, 2018. The ATS international conference is the longest running, large-scale conference in the world offering groundbreaking research in pulmonary, critical care, and sleep medicine. In this activity, 2 experts summarize the key learnings from this year’s conference focusing on strategies in interstitial lung disease (ILD).

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
116x140 ASTHMA AAAAI

Clinical Issues In Severe Asthma: Debates and Discussions About Personalizing Patient Management

Format: Webcast

During this web-based Clinical Issues™ program, a panel of expert faculty will discuss and debate a series of topics related to comprehensively evaluating and longitudinally managing patients with severe asthma, including how the evolving evidence base should shape clinical decision-making and implications of new study data presented at the 2018 American Thoracic Society International Conference.

Take Course »

Credits: 1.5 AMA PRA Category 1 Credit™
910647e 116 x 140

Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis: Refining Approaches to Diagnosis, Prognosis, and Treatment

Format: Webcast

The content for this activity is based on the satellite symposium Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis: Refining Approaches to Diagnosis, Prognosis, and Treatment that was presented on October 24, 2016 in Los Angeles, CA. Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic progressive fibrotic lung disease of unknown cause. Early diagnosis is a prerequisite for earlier treatment and, potentially, improved long-term clinical outcomes. Familiarity with novel treatment approaches that hold the promise of slowing disease progression and with the recent guideline recommendations is essential for all clinicians involved in the care of patients with IPF. Individualizing treatment is important in light of potential improved adherence to both drug therapy and health behaviors. 

Register »

 

Credits: 1.25 AMA PRA Category 1 Credit(s)™
DERM 116x140

Perspectives from the American Academy of Dermatology 2017 Meeting: Clinical Strategies and Scientific Advances in Atopic Dermatitis

Format: Webcast

After many years of little movement in new therapies for patients with atopic dermatitis (AD), significant growth in researching the pathogenesis of AD has resulted in a better understanding of its causes, which has led to new protein targets for novel monoclonal antibodies (mABs). Often diagnosed in infancy, AD can persist into adulthood, affecting 3% to 5% of adults in the United States. Approximately 20% of children and adult patients have been diagnosed with moderate-to-severe AD. For this patient population, these latest advances continue to offer hope, as the current standard of care, which largely centers on symptom management, is suboptimal. This enduring video-based roundtable activity provides the latest updates on AD, including data on emerging and novel treatment options. Expert clinical faculty will also discuss the latest research in AD presented at the 41st Annual Hawaii Dermatology Seminar.  

Take Course »

Credits: 1.00 AMA PRA Category 1 Credit(s)™

See All Courses »